Antonios O Aliprantis MD PhD
Osteoarthritis, Osteoporosis & Bone Metabolism, Scleroderma & Related
Director, Osteoarthritis Center, Brigham and Women's Hospital
Join to View Full Profile
850 Boylston StSte 130Chestnut Hill, MA 02467
Phone+1 617-732-9519
Fax+1 617-732-9577
Dr. Aliprantis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Rheumatology, 2003 - 2007
NYU Grossman School of MedicineResidency, Internal Medicine, 2001 - 2003- New York University School of MedicineClass of 2001
Certifications & Licensure
MA State Medical License 2003 - 2026
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 12 citationsQuantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lin...Jia Yao Phuah, Brian M Maas, Aimin Tang, Ying Zhang, Luzelena Caro
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023-12-31 - 9 citationsVericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, Frank Donath, Rainard Fuhr
American Journal of Cardiovascular Drugs. 2023-03-01 - 13 citationsA phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese ...Yuji Orito, Naoyuki Otani, Yuki Matsumoto, Katsukuni Fujimoto, Nobuyuki Oshima
Clinical and Translational Science. 2022-07-01
Press Mentions
- A Potent Broadly Neutralizing Human RSV Antibody Targets Conserved Site IV of the Fusion GlycoproteinSeptember 12th, 2020
Grant Support
- Regulation Of Osteoclast Biology By Anion Exchanger SLC4A2 In Mouse And Human SysNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- Novel Regulatory Mechanisms Of The Osteoclast Transcriptional ProgramNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2011
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
